We are live on ! Find out more
Fifth Third Bancorp

Fifth Third Bancorp Portfolio holdings

AUM $54.7B
1-Year Est. Return 26.51%
This Fund
S&P 500
This Quarter Est. Return
+8.18%
1 Year Est. Return
+26.51%
3 Year Est. Return
+84.46%
5 Year Est. Return
+101.09%
10 Year Est. Return
+314.66%
AUM
$22.7B
AUM Growth
+$1.17B
Cap. Flow
-$294M
Cap. Flow %
-1.3%
Top 10 Hldgs %
26.53%
Holding
2,889
New
135
Increased
1,025
Reduced
977
Closed
282

Sector Composition

Rank Sector Weight
1 Technology 19.78%
2 Healthcare 9.03%
3 Financials 8.77%
4 Consumer Discretionary 7.25%
5 Industrials 6.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TAN icon
1126
Invesco Solar ETF
TAN
$1.47B
$106K ﹤0.01%
1,478
-300
-17% -$21.6K
AR icon
1127
Antero Resources
AR
$10.9B
$106K ﹤0.01%
4,581
+1,136
+33% +$25.2K
OMAB icon
1128
Grupo Aeroportuario Centro Norte
OMAB
$4.99B
$105K ﹤0.01%
1,243
-518
-29% -$44.7K
IHI icon
1129
iShares US Medical Devices ETF
IHI
$3.02B
$104K ﹤0.01%
1,849
+16
+0.9% +$881
RRX icon
1130
Regal Rexnord
RRX
$14.2B
$104K ﹤0.01%
678
+70
+12% +$9.53K
SSD icon
1131
Simpson Manufacturing
SSD
$7.98B
$104K ﹤0.01%
749
+179
+31% +$22K
MBB icon
1132
iShares MBS ETF
MBB
$39B
$103K ﹤0.01%
1,109
-5,523
-83% -$519K
XOP icon
1133
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$3.42B
$103K ﹤0.01%
801
FOXF icon
1134
Fox Factory Holding Corp
FOXF
$776M
$103K ﹤0.01%
950
+7
+0.7% +$716
IONS icon
1135
Ionis Pharmaceuticals
IONS
$9.35B
$103K ﹤0.01%
2,500
-500
-17% -$19.2K
DTM icon
1136
DT Midstream
DTM
$14.9B
$102K ﹤0.01%
2,061
-76
-4% -$3.64K
FBGX
1137
DELISTED
UBS AG FI Enhanced Large Cap Growth ETN
FBGX
$102K ﹤0.01%
170
PEN icon
1138
Penumbra
PEN
$12.5B
$101K ﹤0.01%
295
+24
+9% +$7.37K
EXG icon
1139
Eaton Vance Tax-Managed Global Diversified Equity Income Fund
EXG
$2.91B
$101K ﹤0.01%
12,800
CHKP icon
1140
Check Point Software Technologies
CHKP
$13.3B
$101K ﹤0.01%
805
-252
-24% -$31.7K
IDCC icon
1141
InterDigital
IDCC
$6.68B
$101K ﹤0.01%
1,044
-56
-5% -$4.54K
CNXC icon
1142
Concentrix
CNXC
$1.36B
$100K ﹤0.01%
1,244
+105
+9% +$9.82K
GEN icon
1143
Gen Digital
GEN
$15.6B
$100K ﹤0.01%
5,392
+1,507
+39% +$26.4K
SIGI icon
1144
Selective Insurance
SIGI
$5.74B
$99.9K ﹤0.01%
1,041
+16
+2% +$1.58K
MMSI icon
1145
Merit Medical Systems
MMSI
$4.43B
$99.5K ﹤0.01%
1,190
+157
+15% +$12.8K
APLE icon
1146
Apple Hospitality REIT
APLE
$3.96B
$99.2K ﹤0.01%
6,565
TPH
1147
DELISTED
Tri Pointe Homes
TPH
$99K ﹤0.01%
3,014
+2,244
+291% +$65.7K
IYE icon
1148
iShares US Energy ETF
IYE
$1.74B
$99K ﹤0.01%
2,310
NAD icon
1149
Nuveen Quality Municipal Income Fund
NAD
$2.71B
$98.8K ﹤0.01%
8,765
+2,794
+47% +$31.5K
AMED
1150
DELISTED
Amedisys
AMED
$98.5K ﹤0.01%
1,077
-200
-16% -$16.4K

Similar funds

Fifth Third Bancorp's Q2 2023 Portfolio in Review

As of Q2 2023, Fifth Third Bancorp held 2,889 positions worth $22.7B, up 5.4% from $21.5B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Fifth Third Bancorp's Q2 2023 filing shows 135 new, 1,025 increased, 977 reduced and 282 closed positions. Its largest new stake was Avantis International Equity ETF: 228,309 shares worth $13.1M. The largest sale was Procter & Gamble, an estimated $39.1M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.

  • Fifth Third Bancorp's largest Q2 2023 buy was Avantis International Equity ETF: 228,309 shares worth $13.1M.
  • Fifth Third Bancorp added most to Eli Lilly in Q2 2023, an estimated $52.9M increase.
  • Fifth Third Bancorp's biggest Q2 2023 reduction was Procter & Gamble, cutting an estimated $39.1M.
  • Fifth Third Bancorp fully exited ProShares Investment Grade-Interest Rate Hedged in Q2 2023, selling an estimated $1.15M.
  • Fifth Third Bancorp's ten largest holdings make up 27% of its $22.7B portfolio in Q2 2023.
  • Fifth Third Bancorp opened 135 new positions and closed 282 in Q2 2023.
  • Fifth Third Bancorp's portfolio value rose 5.4% quarter-over-quarter to $22.7B.

Based on Fifth Third Bancorp's 13F filing for Q2 2023, filed 26 Jul 2023.